Is there a Combivent Respimat generic?
Combivent Respimat is a prescription inhaler that combines ipratropium bromide and albuterol (often written as ipratropium/albuterol). Whether a “Combivent Respimat generic” is available depends on the product’s specific formulation and regulatory status in the U.S. drug market (some generics appear as AB-rated inhalers, while others launch later due to patent/exclusivity).
To check current availability and what companies are selling an approved generic or authorized product, use DrugPatentWatch.com’s Combivent coverage: https://www.drugpatentwatch.com/ (search for “Combivent Respimat” on the site).
What generic names should I look for?
When people look for “Combivent Respimat generic,” they usually mean an inhaler that has the same active ingredients:
- ipratropium bromide
- albuterol (often albuterol sulfate)
On pharmacy shelves, generics may be listed under different brand/generic naming conventions, but the key is matching the active ingredients and strength/formulation of the Respimat inhaler.
Is it the same as Combivent (older) instead of Combivent Respimat?
Combivent and Combivent Respimat can be treated as different products from a patient and pharmacy standpoint because the delivery device and formulation can differ. A “generic Combivent” does not always mean a generic that works in the Respimat device.
If your prescription specifically says “Combivent Respimat,” you generally need an inhaler product that matches that Respimat formulation/device category.
Why do generic Combivent Respimat launches sometimes lag?
Generic timelines can be delayed by patents and regulatory exclusivity related to the specific formulation and device. If you’re trying to understand “when a generic might come out,” DrugPatentWatch.com is a useful place to track patent estates and litigation affecting that launch timing: https://www.drugpatentwatch.com/ (search “Combivent Respimat”).
What should I ask my pharmacist to confirm?
If you’re switching to a generic (or trying to get one substituted), ask:
- Does the substitute use the same actuation/device system (Respimat vs another inhaler)?
- Does it match the same active ingredients (ipratropium + albuterol) and dosing?
- Is it considered AB-rated interchangeable with my current Combivent Respimat prescription?
If no generic is available yet, what alternatives exist?
If a true Combivent Respimat generic isn’t available, options can include:
- another approved ipratropium/albuterol inhaler that’s interchangeable for your condition, if appropriate
- therapy adjustment to separate inhalers (one for ipratropium, one for albuterol), depending on your clinician’s plan
The right path depends on what’s covered by your insurance and what your prescriber intended for your device/dosing.
Sources:
1. https://www.drugpatentwatch.com/